article thumbnail

Medicinal cannabis: the route to good manufacturing practice registration

European Pharmaceutical Review

After the substance became legal in the UK in 2018, pharmaceutical companies have faced numerous obstacles to attain a fairer position in the industry. How do you see the evolution of cannabis-based medicines, particularly when it comes to the ‘specials’ or fully licensed drug routes? He founded Celadon in 2018.

Medicine 129
article thumbnail

Novo Nordisk grabs NASH drug from Ventus in $703m deal

pharmaphorum

The deal – which includes additional milestones of up to $633 million plus tiered royalties on sales and R&D funding – focuses on VENT-01, the lead drug in Ventus’ peripherally-restricted NLRP3 inhibitor programme, which is currently in preclinical development.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Medical imaging modalities: A spotlight on the liver

Clarivate

Liver cancer and focal liver lesions Liver cancer ranks as the third-leading cause of cancer-related deaths worldwide. [5] We specialize in the development of robust and compelling value communication materials, including value story slide decks, global value and reimbursement dossiers, objection handlers and publications.

Medical 59
article thumbnail

Aquedeon Medical, Inc. Receives FDA IDE Approval for the Duett Vascular Graft System

Legacy MEDSearch

a Silicon Valley pioneering medical device company specializing in novel cardiothoracic solutions, is pleased to announce a significant milestone following receipt of FDA Investigational Device Exemption (IDE) approval to conduct a staged pivotal clinical trial for its Duett Vascular Graft System in the United States. Aquedeon Medical, Inc.,

Medical 52
article thumbnail

mRNA therapeutics: a limitless revolution in medicine

European Pharmaceutical Review

Targeted entry of mRNA into human cells is a challenging process that requires special delivery systems to protect the therapeutic mRNA from degradation…”. The first drug to be approved with an ionised lipid was Onpattro® (patisiran) for the treatment of hereditary transthyretin protein amyloidosis in 2018. About the authors.

Medicine 106
article thumbnail

Healthcare Industry Leaders and Workplace Equity Champions Announced as 2023 Award Recipients by the Healthcare Businesswomen’s Association

Pharma Marketing Network

In three short years, Kite has grown to be the largest CAR T-cell therapy company in the world, with an extensive in-house manufacturing network devoted to creating this specialized treatment for patients. These experiences have empowered Christi to become a leading industry voice advocating fiercely for patients.

article thumbnail

Three timesaving ways for research offices to connect faculty with funding opportunities

Clarivate

Curated Lists support special initiatives such as DEI-related research. Founded in 1957 as a small branch college, it has grown into a thriving research institution serving 30,000 students and supporting medical, dental and law schools. Links to Curated Lists can be shared on Twitter or other social media platforms.